We analyzed TF ChIP-seq data generated in breast cancer-related cells to characterize their genome-wide binding sites for susceptible TFs that have been identified in breast cancer from our prior work (16) (Figure 1B; see the ‘Materials and methods’ section). This evidence concerns the gene TF and breast carcinoma.